A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
Phase 4
Active, not recruiting
- Conditions
- Fibrillary Glomerulonephritis
- Interventions
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- NephroNet, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05546047
- Locations
- ๐บ๐ธ
Stanford University, Stanford, California, United States
๐บ๐ธNortheast Clinical Research Center, Bethlehem, Pennsylvania, United States
๐บ๐ธGeorgia Nephrology DBA Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- NephroNet, Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT05535920
- Locations
- ๐บ๐ธ
Georgia Nephrology DBA Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States
๐บ๐ธBalboa Research, La Jolla, California, United States
๐บ๐ธNephrology Associates of Northern Illinois and Indiana (NANI), Fort Wayne, Indiana, United States
Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy
Phase 4
Withdrawn
- Conditions
- Renal Disease
- Interventions
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- NephroNet, Inc.
- Registration Number
- NCT04080076
- Locations
- ๐บ๐ธ
Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath